Sebastien Wälchli Department of Cellular Therapy, Department of Oncology Oslo University Hospital-Radiumhospitalet Biography Publications Institution JoVE Articles Sebastien Wälchli has not added a biography. If you are Sebastien Wälchli and would like to personalize this page please email our Author Liaison for assistance. Publications Artesunate Shows Potent Anti-tumor Activity in B-cell Lymphoma Journal of Hematology & Oncology. Feb, 2018 | Pubmed ID: 29458389 Human C-SRC Kinase (CSK) Overexpression Makes T Cells Dummy Cancer Immunology, Immunotherapy : CII. Apr, 2018 | Pubmed ID: 29248956 A TCR-based Chimeric Antigen Receptor Scientific Reports. Sep, 2017 | Pubmed ID: 28878363 T Cell Therapy Targeting a Public Neoantigen in Microsatellite Instable Colon Cancer Reduces Tumor Growth Oncoimmunology. Month, 2017 | Pubmed ID: 28507809 Targeting B-cell Neoplasia with T-cell Receptors Recognizing a CD20-derived Peptide on Patient-specific HLA Oncoimmunology. May, 2016 | Pubmed ID: 27467957 Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants Molecular Therapy : the Journal of the American Society of Gene Therapy. 09, 2016 | Pubmed ID: 27377043 Unpredicted Phenotypes of Two Mutants of the TcR DMF5 Journal of Immunological Methods. Oct, 2015 | Pubmed ID: 26079729 Soluble T-cell Receptors Produced in Human Cells for Targeted Delivery PloS One. Month, 2015 | Pubmed ID: 25875651 Alloreactive Cytotoxic T Cells Provide Means to Decipher the Immunopeptidome and Reveal a Plethora of Tumor-associated Self-epitopes Proceedings of the National Academy of Sciences of the United States of America. Jan, 2014 | Pubmed ID: 24344295 Invariant Chain As a Vehicle to Load Antigenic Peptides on Human MHC Class I for Cytotoxic T-cell Activation European Journal of Immunology. Mar, 2014 | Pubmed ID: 24293164 BiP Negatively Affects Ricin Transport Toxins. May, 2013 | Pubmed ID: 23666197 A Practical Approach to T-cell Receptor Cloning and Expression PloS One. Month, 2011 | Pubmed ID: 22132171 A Spheroid Killing Assay by CAR T Cells Pierre Dillard1, Hakan Köksal1, Else-Marit Inderberg1, Sebastien Wälchli1 1Department of Cellular Therapy, Department of Oncology, Oslo University Hospital-Radiumhospitalet JoVE 58785 Cancer Research
A Spheroid Killing Assay by CAR T Cells Pierre Dillard1, Hakan Köksal1, Else-Marit Inderberg1, Sebastien Wälchli1 1Department of Cellular Therapy, Department of Oncology, Oslo University Hospital-Radiumhospitalet JoVE 58785 Cancer Research
